BCH-BB694 Gene Therapy Safely Treating Severe SCD Patients in Pilot Trial
News
BCH-BB694 — an experimental gene therapy targeting the BCL11A gene — safely increased the levels of fetal hemoglobin and prevented disease-associated complications in six people with severe sickle cell ... Read more